Beacon’s Post

Dive into hemophilia A gene therapy! 🧬 Learn who's eligible and what to expect from the latest clinical data. Enhance care with new insights on safety and efficacy. Register here: http://ms.spr.ly/6048c4l1k #HemophiliaATherapy 🩺💡

Dive into hemophilia A gene therapy! 🧬 Learn who's eligible and what to expect from the latest clinical data. Enhance care with new insights on safety and efficacy. Register here: http://ms.spr.ly/6045Y8wch #HemophiliaATherapy 🩺💡

Cell and gene therapy in the Asia-Pacific region https://lnkd.in/efNFUyFj learnings from local case studies. In this update, we share two case studies that explore how local innovators in the cell and gene therapy space in Asia-Pacific are addressing some of the major challenges for access in the region: that of overcoming complex manufacturing and delivery and improving affordability. https://lnkd.in/efNFUyFj #MarketAccess #HEOR #WeAreAvalereHealth

The Gene Therapy Equation: Costs, Value and Future Directions 🧬✨ In our latest episode of Healthcare Matters, we’re joined by Dr. Anne Sydor, Director of Research Development at GHLF, to explore the groundbreaking potential of gene therapy, the insights into the high costs of treatments, the challenges posed by current regulations and the future of payment models and sustainable deployment. Robert Popovian Tune in for an enlightening discussion on the complexities and future directions on this fascinating topic here https://lnkd.in/gbmF2SFP #GeneTherapy #HealthcareMatters #MedicalBreakthroughs #InnovativeMedicine

Everything you need to know about GENE THERAPY for hemophilia A and B. First illustrated review describing basic principles, current evidence &clinical implementation by Cihan Ay et al published in @haemophilia journal It has been a wonderful experience curating the illustrations for the team. Art4Science (https://lnkd.in/e5eiWVtF) https://lnkd.in/eU2jv33N #genetherapy #haematology #hemophilia

ELIQUENT Expert - Katie McKay - examines two new FDA guidance documents impacting Cell & Gene Therapy (CGT) products. Read Katie's analysis at https://lnkd.in/e_cqsnDG and learn more about ELIQUENT Life Sciences CGT capabilities at ELIQUENT.com

How is investment in the cell and gene therapy sector shaping up this year? Our data shows that through the first half of 2024, there have been over $11 billion in deals, approaching the annual total for 2023. Dive into ARM's full quarterly data on investments, clinical trials, and total developers on our website. 📊 https://lnkd.in/ebVuvmKK #cellandgenetherapy #data

Decoding raw material quality and regulatory standards in cell and gene therapy! Understand the relationship between raw material selection and CGT manufacturing success in this webinar. Register now >>> https://hubs.ly/Q02QMhcK0 Sartorius

The EOS Intelligence #LifeSciences team's April topic is CGT. If this is a topic that interests you, look out for #eosperspectives from Stuart Wagner, MBA & Bhabesh Panigrahi #cellandgenetherapy #eosintelligence

Please take to few minutes to complete this short survey to help the program chairs design programs that meet your needs.